Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy

Sleep

Volumn 31, Issue 3, 2008, Pages 342-347

  Kim, Seog Ju ^a   Lyoo, In Kyoon ^b   Lee, Yujin S ^c   Sung, Young Hoon ^d   Kim, Hengjun J ^b   Kim, Jihyun H ^b   Kim, Kye Hyun ^b   Jeong, Do Un ^b,e  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul Metropolitan Eunpyeong Hospital   (South Korea)

^d MCLEAN HOSPITAL   (United States)

^e Seoul National University Hospital   (South Korea)

Author keywords

GABA; Medial prefrontal cortex; Narcolepsy; Proton MR spectroscopy

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID;

ADULT; ARTICLE; BASAL GANGLION; CATAPLEXY; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; NARCOLEPSY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SLEEP DISORDER;

EID: 42149123249     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/31.3.342     Document Type: Article

References (28)

1. Siegel JM. Narcolepsy: a key role for hypocretins (orexins). Cell 1999;98:409-12.
2. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
3. Overeem S, Scammell TE, Lammers GJ. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol 2002;15:739-45.
4. Hajak G, Geisler P. Orchestrating sleep-wake functions in the brain. Nat Med 2003;9:170-1.
5. Gottesmann C. GABA mechanisms and sleep. Neuroscience 2002;111:231-9.
6. Jones BE. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 2005;26:578-86.
7. Lyoo IK, Renshaw PF. Magnetic resonance spectroscopy: current and future applications in psychiatric research. Biol Psychiatry 2002;51:195-207
8. Ellis CM, Simmons A, Lemmens G, Williams SC, Parkes JD. Proton spectroscopy in the narcoleptic syndrome. Is there evidence of a brainstem lesion? Neurology 1998;50:S23-6.
9. Lodi R, Tonon C, Vignatelli L, et al. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients. Neurology 2004;63:1513-5.
10. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-13.
11. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9.
12. Kaufmann C, Schuld A, Pollmacher T. Auer DP. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology 2002;58:1852-5.
13. Joo EY, Tae WS, Kim JH, Kim BT. Hong SB. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol 2004;56:437-40.
14. Joo EY, Hong SB, Tae WS, et al. Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage 2005;28:410-6.
15. Rothman DL, Petroff OA, Behar KL, Mattson RH. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993;90:5662-6.
16. Yamasue H, Fukui T, Fukuda R, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 2002;13:2133-7.
17. Arnulf I, Konofal E, Gibson KM, et al. Effect of genetically caused excess of brain gamma-hydroxybutyric acid and GABA on sleep. Sleep 2005;28:418-24.
18. Mamelak M, Black J, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and day-time alertness in narcolepsy. Sleep 2004;27:1327-34.
19. Katsuki H, Akaike A. Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation. Neuroreport 2005;16:1157-61.
20. Viggiano A, Monda M, Viggiano A, Fuccio F, De Luca B. Extracellular GABA in the medial hypothalamus is increased following hypocretin-1 administration. Acta Physiol Scand 2004;182:89-94.
21. Wu M, Zhang Z, Leranth C, Xu C, van den Pol AN, Alreja M. Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition. J Neurosci 2002;22:7754-65.
22. Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002;104:83-9.
23. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998;18:7962-71.
24. Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci 2003;23:4951-7.
25. John J, Wu MF, Kodama T, Siegel JM. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol 2003;548:557-62.
26. Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res 2001;10:75-81.
27. Ham BJ, Chey J, Yoon SJ, et al. Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: a proton magnetic resonance spectroscopy study. Eur J Neurosci 2007;25:324-9.
28. Kamba M, Inoue Y, Higami S, Suto Y. Age-related changes in cerebral lactate metabolism in sleep-disordered breathing. Neurobiol Aging 2003;24:753-60.